Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

NCT06526884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 570

Last updated 2026-05-18

No results posted yet for this study

Summary

The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.

Conditions

  • Pneumonia
  • Syncope
  • Congestive Heart Failure
  • Cellulitis
  • Pyelonephritis
  • AKI - Acute Kidney Injury
  • Diabetic Foot Infection
  • Osteomyelitis

Interventions

OTHER

Next Day Clinic

A dedicated Next Day Clinic team consisting of a clinician and nurse case manager will provide care and specialist referrals to patients within 24 hours of an ED visit that would have resulted in hospitalization without this novel hospital avoidance initiative.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-22
Primary Completion
2026-01-20
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526884 on ClinicalTrials.gov